Time limits apply in Arkansas. Find out if you still qualify.
Start Your Free Review
Answer 2-3 quick questions to review your potential case.
Verified against court records, regulatory records, and peer-reviewed research.
Last reviewed against primary sources: June 11, 2026
Statute of Limitations
Arkansas: 3 years from discovery of injury (Ark. Code Ann. § 16-116-103)
3 years from BIA-ALCL diagnosis or discovery of injury connection
Where to File in Arkansas
Arkansas plaintiffs with Allergan BIOCELL claims file in MDL 2921 in the District of New Jersey. Arkansas has a 3-year product liability statute under Ark. Code Ann. § 16-116-103, providing a longer window than neighboring states. Arkansas applies the discovery rule. Little Rock and Fayetteville cosmetic surgery markets placed Allergan BIOCELL products during the 2005–2019 period. Women in Arkansas with BIA-ALCL diagnoses from 2023 onward are within the 3-year statute.
Exposure in Arkansas
Source: FDA MAUDE Adverse Event Database
Source: Allergan/AbbVie Press Release; FDA Safety Communication